Search for clinical trials in your area or further afield. We recommend speaking to your medical team if you find a trial you think you may be eligible for.
Researchers are conducting the PROMPT trial to see if the study drug (pembrolizumab) can be used as a maintenance treatment to slow the growth/return of cancer after treatment with paclitaxel (standard chemotherapy drug). Normally, after receiving paclitaxel, patients are observed without treatment as maintenance treatment is not standard for this …
For a woman who's at increased of developing ovarian cancer, the standard practice is to offer an operation to remove both tubes and ovaries (risk reducing salpingo oophorectomy' or RRSO). Removing both tubes and ovaries (RRSO) is at present the most effective or best way we have to prevent ovarian cancer in women who are at increased risk. This is…
In this study, researchers want to find out how safe and effective it is to use two new drugs, alone or in combination, to treat recurrent, low grade serous ovarian cancer (LGSOC). The drugs used in this trial are both a type of drug called a kinase inhibitor. Kinase inhibitors block cancer cell growth. The drugs involved in this trial are: …
Gynaecological cancer patients are all managed within 34 Cancer Centres located across the UK. These centres are only likely to see 1–5 new patients per year with rare gynaecological cancers. The low numbers of these cancers means that no single doctor or centre in the UK (or internationally) can hope to gain sufficient experience to be able to con…
The aims of the trial are to: help diagnose ovarian cancer earlier when treatment is likely to work better help identify which women need further investigations for possible ovarian cancer and reduce unnecessary tests, hospital visits and distress in women who do not have ovarian cancer try to develop a blood test that is more specific an…
Genetic testing in ovarian cancer patients is now being implemented across the NHS. It's hoped that by doing this, patients across the NHS will have even better treatments and that in some families, cancers will be prevented. This trial offers a genetic test to women with certain types of ovarian cancer. This is to detect gene alterations that …
Sign up to receive emails from Target Ovarian Cancer, including our monthly newsletter, and be the first to hear about campaigns, upcoming events and fundraising inspiration.
Sign up
